Trial
NCT04241159
Study to Explore the Safety and Feasibility of Allogeneic Young Plasma Infusion in Older Adults
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Frailty Syndrome
Intervention
Allogeneic Young Plasma
Why stopped
Protocol required revisions and application was withdrawn from the IRB.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-22